Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China-Reference-Cited by-同舟云学术

Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China

Published:2019-11-12 Issue:1 Volume:9 Page:374-384
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Duan Rufei¹,Qiao Youlin¹^ORCID,Clifford Gary²,Zhao Fanghui¹^ORCID

Affiliation:

1. National Cancer Center National Clinical Research Center for Cancer Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. International Agency for Research on Cancer Lyon France

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2697

Reference37 articles.

1. Biological agents. Volume 100 B. A review of human carcinogens;IARC Working Group on the Evaluation of Carcinogenic Risks to Humans;IARC Monogr Eval Carcinog Risks Hum,2012

2. Worldwide burden of cancer attributable to HPV by site, country and HPV type

3. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

4. Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination

5. International trends in anal cancer incidence rates;Islami F;Int J Epidemiol,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies;Journal of Medical Virology;2024-09

2. CNKSR2 expression is correlated with immune infiltrates in Cervical Cancer as a favorable prognostic factor;Journal of Cancer;2024

3. Impact of Achieving WHO's 90-70-90 Targets on Cervical Cancer Elimination and Potential Benefits in Preventing Other HPV-Related Cancers in China;2024

4. Assessing the burden of HPV-related head and neck cancers in mainland China: protocol of a nationwide, multisite, cross-sectional study;BMJ Open;2023-11

5. The impact of the COVID‐19 pandemic on the prevalence and genotype distribution of HPV infection in Beijing, China;Journal of Medical Virology;2023-10